back to VALUED HEALTHCARE CONSULTING LTD detail ACCOUNTS - Final Accounts preparation
Caseware UK (AP4) 2016.0.181 2016.0.181 2017-12-312017-12-31The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.truetrueThe principal activity of the company is that of specialist medical practice activities.false2017-01-01 SC544456 2016-12-31 SC544456 2017-01-01 2017-12-31 SC544456 2017-12-31 SC544456 c:Director1 2017-01-01 2017-12-31 SC544456 d:CurrentFinancialInstruments 2017-12-31 SC544456 d:CurrentFinancialInstruments d:WithinOneYear 2017-12-31 SC544456 d:ShareCapital 2017-12-31 SC544456 d:RetainedEarningsAccumulatedLosses 2017-12-31 SC544456 c:FRS102 2017-01-01 2017-12-31 SC544456 c:AuditExempt-NoAccountantsReport 2017-01-01 2017-12-31 SC544456 c:FullAccounts 2017-01-01 2017-12-31 SC544456 c:PrivateLimitedCompanyLtd 2017-01-01 2017-12-31 iso4217:GBP


Registered number: SC544456












VALUED HEALTHCARE 
CONSULTING LIMITED



UNAUDITED
INFORMATION FOR FILING WITH THE REGISTRAR
FOR THE YEAR ENDED 31 DECEMBER 2017

 
VALUED HEALTHCARE CONSULTING LIMITED

REGISTERED NUMBER:SC544456

BALANCE SHEET
AS AT 31 DECEMBER 2017

2017
Note
£

  

Current assets
  

Debtors: amounts falling due within one year
  
1,209

Cash at bank and in hand
 4 
2,153

  
3,362

Creditors: amounts falling due within one year
  
(4,621)

Net current (liabilities)/assets
  
 
 
(1,259)

Total assets less current liabilities
  
(1,259)

  

Net (liabilities)/assets
  
(1,259)


Capital and reserves
  

Called up share capital 
  
10

Profit and loss account
  
(1,269)

  
(1,259)


The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.


 
Page 1
 

 
VALUED HEALTHCARE CONSULTING LIMITED

REGISTERED NUMBER:SC544456

BALANCE SHEET (CONTINUED)
AS AT 31 DECEMBER 2017

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 



W Craig
Director

Date: 22 January 2018
The notes on pages 3 to 6 form part of these financial statements.

Page 2
 

 
VALUED HEALTHCARE CONSULTING LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2017

1.


General information

Valued Healthcare Consulting Limited is a private limited company incorporated in Scotland. The registered address is 64 Annfield Terrace, Aberdeen, United Kingdom, AB10 6TJ.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The following principal accounting policies have been applied:

 
2.2

Going concern

The director, having made due and careful enquiry, is of the opinion that the Company has adequate working capital to execute its operations over the next 12 months.  The director, therefore, has made an informed judgement, at the time of approving the financial statements, that there is a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. As a result, the director will continue to adopt a going concern basis of accounting in preparing the annual financial statements.

 
2.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.4

Debtors

Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.5

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

Page 3
 

 
VALUED HEALTHCARE CONSULTING LIMITED
 

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2017

2.Accounting policies (continued)

 
2.6

Financial instruments

The Company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in non-puttable ordinary shares.

Debt instruments (other than those wholly repayable or receivable within one year), including loans and other accounts receivable and payable, are initially measured at present value of the future cash flows and subsequently at amortised cost using the effective interest method. Debt instruments that are payable or receivable within one year, typically trade debtors and creditors, are measured, initially and subsequently, at the undiscounted amount of the cash or other consideration expected to be paid or received. However, if the arrangements of a short-term instrument constitute a financing transaction, like the payment of a trade debt deferred beyond normal business terms or financed at a rate of interest that is not a market rate or in case of an out-right short-term loan not at market rate, the financial asset or liability is measured, initially, at the present value of the future cash flow discounted at a market rate of interest for a similar debt instrument and subsequently at amortised cost.

Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Statement of comprehensive income.

For financial assets measured at amortised cost, the impairment loss is measured as the difference between an asset's carrying amount and the present value of estimated cash flows discounted at the asset's original effective interest rate. If a financial asset has a variable interest rate, the discount rate for measuring any impairment loss is the current effective interest rate determined under the contract.

For financial assets measured at cost less impairment, the impairment loss is measured as the difference between an asset's carrying amount and best estimate of the recoverable amount, which is an approximation of the amount that the Company would receive for the asset if it were to be sold at the balance sheet date.

Financial assets and liabilities are offset and the net amount reported in the Balance sheet when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

 
2.7

Creditors

Short term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.8

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting. Dividends on shares recognised as liabilities are recognised as expenses and classified within interest payable.

Page 4
 

 
VALUED HEALTHCARE CONSULTING LIMITED
 

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2017

2.Accounting policies (continued)

 
2.9

Taxation

Tax is recognised in the Statement of comprehensive income, except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.


3.


Debtors

2017
£


Trade debtors
1,209

1,209



4.


Cash and cash equivalents

2017
£

Cash at bank and in hand
2,153

2,153



5.


Creditors: Amounts falling due within one year

2017
£

Corporation tax
2,106

Other creditors
715

Accruals and deferred income
1,800

4,621


Page 5
 

 
VALUED HEALTHCARE CONSULTING LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2017

6.


Related party transactions

CONTROL

During the current year, the company was controlled by the director.

TRANSACTIONS

During the year, the company received credits of £715 from the director. This balance is due by the company to the director at the year end.

Page 6